CHI's PK/PD of Novel Constructs
Organization: Cambridge Healthtech Institute
|Event Date/Time: Nov 11, 2013 / 8:00 am - (EST)||End Date/Time: Nov 12, 2013 / 4:00 pm - (EST)|
Understanding the metabolism of novel constructs in animal models and clinical studies is critical to their success. This year’s conference will cover the role of PK in optimizing novel constructs, look at opportunities for improvement of antibody-drug conjugates, share examples of implementing mechanistic modeling to inform drug design, and review the state-of-the-art techniques for applying multi-specific medicines. Drafting successful PK/PD principles and translating candidates from preclinical development to the clinic will be developed. This conference is part of Immunogenicity Summit 2013.